Abstract
Antibodies directed against tumor-associated antigens are emerging as effective treatments for a number of cancers, although the mechanism(s) of action for some are unclear and still under investigation. We have previously examined a chimeric IgE antibody (MOv18 IgE), against the ovarian tumor-specific antigen, folate binding protein (FBP), and showed that it can direct human PBMC to kill ovarian cancer cells. We have developed a three-color flow cytometric assay to investigate the mechanism by which IgE receptors on U937 monocytes target and kill ovarian tumor cells. U937 monocytes express three IgE receptors, the high-affinity receptor, FcεRI, the low-affinity receptor, CD23, and galectin-3, and mediate tumor cell killing in vitro by two mechanisms, cytotoxicity, and phagocytosis. Our results suggest that CD23 mediates phagocytosis, which is enhanced by upregulation of CD23 on U937 cells with IL-4, whereas FcεRI mediates cytotoxicity. We show that effector : tumor cell bridging is associated with both activities. Galectin-3 does not appear to be involved in tumor cell killing. U937 cells and IgE exerted ovarian tumor cell killing in vivo in our xenograft model in nude mice. Harnessing IgE receptors to target tumor cells suggests the potential of tumor-specific IgE antibodies to activate effector cells in immunotherapy of ovarian cancer.
Similar content being viewed by others
Abbreviations
- ADCC:
-
Antibody-dependent cell-mediated cytotoxicity
- ADCP:
-
Antibody-dependent cell-mediated phagocytosis
- FBP:
-
Folate binding protein
- sFcεRIα:
-
Soluble FcεRI α-chain
- CM:
-
Complete medium
- PI:
-
Propidium iodide
- CFSE:
-
Carboxy-fluorescein diacetate, succinimidyl ester
- NIP:
-
4-Hydroxy-3-nitro-phenacetyl
References
Glennie MJ, van de Winkel JG (2003) Renaissance of cancer therapeutic antibodies. Drug Discov Today 8:503–510
Carter PJ (2006) Potent antibody therapeutics by design. Nat Rev Immunol 6:343–357
Brüggeman M, Caskey HM, Teale C, Waldmann H, Williams G, Surani NA, Neuberger MS (1987) Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med 166:1351–1361
Dyer MJS, Hale G, Hayhoe FGJ, Waldmann H (1989) Effects in vivo in patients with lymphoid malignancies; influence of antibody isotype. Blood 73:1431–1439
Clynes RA, Towers TL, Presta LG, Ravetch JV (2000) Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat Med 6:443–446
Reali E, Greiner JW, Corti A, Gould HJ, Bottazzoli F, Paganelli G, Schlom J, Siccardi AG (2001) IgEs targeted on tumor cells: therapeutic activity and potential in the design of tumour vaccines. Cancer Res 61:5517–5522
Gould HJ, Sutton BJ, Beavil AJ, Beavil RL, McCloskey N, Coker HA, Fear D, Smurthwaite L (2003) The biology of IgE and the basis of allergic disease. Annu Rev Immunol 21:579–628
Gould HJ, Mackay GA, Karagiannis SN, O’Toole CM, Marsh PJ, Daniel BE, Coney LR Zurawski VR Jr, Joseph M, Capron M, Gilbert M, Murphy GF, Korngold R (1999) Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma. Eur J Immunol 29:3527–3537
Karagiannis SN, Wang Q, East N, Burke F, Riffard S, Bracher MG, Thompson RG, Durham SR, Schwartz LB, Balkwill FR, Gould HJ (2003) Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells. Eur J Immunol 33:1030–1040
Campbell IG, Jones TA, Foulkes WD, Trowsdale J (1991) Folate binding protein is a marker for ovarian cancer. Cancer Res 51:5329–5338
Coney LR, Tomassetti A, Carayannopoulos L, Frasca V, Kamen BA, Colnaghi MI, Zurawski VR Jr (1991) Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res 51:6125–6132
Toffoli G, Cernigoi C, Russo A, Gallo A, Bagnoli M, Boiocchi M (1997) Overexpression of folate binding protein in ovarian cancers. Int J Cancer 74:193–198
Williams J, Johnson S, Mascali JJ, Smith H, Rosenwasser LJ, Borish L (1992) Regulation of low affinity IgE receptor (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects. J Immunol 149:2823–2829
Wong HL, Lotze MT, Wahl LM, Wahl SM (1992) Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes. J Immunol 148:2118–2125
Boltz-Nitulescu G, Willheim M, Spittler A, Leutmezer F, Tempfer C, Winkler S (1995) Modulation of IgA, IgE, and IgG Fc receptor expression on human mononuclear phagocytes by 1 alpha,25-dihydroxyvitamin D3 and cytokines. J Leukoc Biol 58:256–262
Maurer D, Fiebiger E, Reininger B, Wolff-Winiski B, Jouvin MH, Kilgus O, Kinet JP, Stingl G (1994) Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals. J Exp Med 179:745–750
Reischl IG, Corvaia N, Effenberger F, Wolff-Winiski B, Kromer E, Mudde GC (1996) Function and regulation of Fc epsilon RI expression on monocytes from non-atopic donors. Clin Exp Allergy 26:630–641
Frigeri LG, Liu FT (1992) Surface expression of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages. J Immunol 148:861–867
Liu FT, Hsu DK, Zuberi RI, Kuwabara I, Chi EY, Henderson WR Jr (1995) Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol 147:1016–1028
Liu FT, Hsu DK, Zuberi RI, Shenhav A, Hill PN, Kuwabara I, Chen SS (1996) Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domain. Biochemistry 35:6073–6079
Yokota A, Kikutani H, Tanaka T, Sato R, Barsumian EL, Suemura M, Kishimoto T (1988) Two species of human Fcε receptor II (FcεRII/CD23): tissue-specific and IL-4-specific regulation of gene expression. Cell 55:611–618
Yokota A, Yukawa K, Yamamoto A, Sugiyama K, Suemura M, Tashiro Y, Kishimoto T, Kikutani H (1992) Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains. Proc Natl Acad Sci USA 89:5030–5034
Mossalayi MD, Paul-Eugene N, Ouaaz F, Arock M, Kolb JP, Kilchherr E, Debre P, Dugas B (1994) Involvement of Fc epsilon RII/CD23 and L-arginine-dependent pathway in IgE-mediated stimulation of human monocyte functions. Int Immunol 6:931–938
Paul-Eugene N, Mossalayi D, Sarfati M, Yamaoka K, Aubry JP, Bonnefoy JY, Dugas B, Kolb JP (1995) Evidence for a role of Fc epsilon RII/CD23 in the IL-4-induced nitric oxide production by normal human mononuclear phagocytes. Cell Immunol 163:314–318
Vouldoukis I, Riveros-Moreno V, Dugas B, Ouaaz F, Becherel P, Debre P, Moncada S, Mossalayi MD (1995) The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc Natl Acad Sci USA 92:7804–7808
Ravetch JV, Kinet JP (1991) Fc receptors. Annu Rev Immunol 9:457–492
Dyall R, Vasovic LV, Clynes RA, Nikolic-Zugic J (1999) Cellular requirements for the monoclonal antibody-mediated eradication of an established solid tumor. Eur J Immunol 29:30–37
Liu FT (2005) Regulatory roles of galectins in the immune response. Int Arch Allergy Immunol 136:385–400
Sundström G, Nilsson K (1976) Establishment and characterization of a human histiocytic cell-line (U937). Int J Cancer 17:565–577
Benard J, Da Silva J, De Blois MC, Boyer P, Duvillard P, Chiric E, Riou G (1985) Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res 45:4970–4979
Balkwill FR, Lee A, Aldam G, Moodie E, Thomas JA, Tavernier J, Fiers W (1986) Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Res 46:3990–3993
Bracher M, Gould HJ, Sutton BJ, Dombrowicz D, Karagiannis SN (2007) Three-colour flow cytometric method to measure antibody-dependent tumour cell killing by cytotoxicity and phagocytosis. J Immunol Methods 323:160–171
Neuberger MS, Williams GT, Mitchell EB, Jouhal SS, Flanagan JG, Rabbitts TH (1985) A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature 314:268–270
Cook JP, Henry AJ, McDonnell JM, Owens RJ, Sutton BJ, Gould HJ (1997) Identification of contact residues in the IgE binding site of human FcεRIα. Biochemistry 36:15579–15588
Wakai M, Pasley P, Sthoeger ZM, Posnett DN, Brooks R, Hashimoto S, Chiorazzi N (1993) Anti-CD23 monoclonal antibodies: comparisons of epitope specificities and modulating capacities for IgE binding and production. Hybridoma 12:25–43
Mavromatis BH, Cheson BD (2004) Novel therapies for chronic lymphocytic leukemia. Blood Rev 18:137–148
Riske F, Hakimi J, Mallamaci M, Griffin M, Pilson B, Tobkes N, Lin P, Danho W, Kochan J, Chizzonite R (1991) High affinity human IgE receptor (Fc epsilon RI). Analysis of functional domains of the alpha-subunit with monoclonal antibodies. J Biol Chem 266:11245–11251
Wang B, Rieger A, Kilgus O, Ochiai K, Maurer D, Fodinger D, Kinet JP, Stingl G (1992) Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J Exp Med 175:1353–1365
Lin S, Cicala C, Scharenberg AM, Kinet JP (1996) The FcεRI β subunit functions as an amplifier of FcεRI γ-mediated cell activation signals. Cell 85:985–995
Tomassetti A, Coney LR, Canevari S, Miotti S, Facheris P, Zurawski VR Jr, Colnaghi MI (1993) Isolation and biochemical characterization of the soluble and membrane forms of folate binding protein expressed in the ovarian carcinoma cell line IGROV1. FEBS Lett 317:143–146
Vercelli D, Helm B, Marsh P, Padlan E, Geha RS, Gould H (1989) The B-cell binding site on human immunoglobulin E. Nature 338:649–651
Keegan AD, Fratazzi C, Shopes B, Baird B, Conrad DH (1991) Characterization of new rat anti-mouse IgE monoclonals and their use along with chimeric IgE to further define the site that interacts with FcεRII and FcεRI. Mol Immunol 28:1149–1154
Kayaba H, Dombrowicz D, Woerly G, Papin JP, Loiseau S, Capron M (2001) Human eosinophils and human high affinity IgE receptor transgenic mouse eosinophils express low levels of high affinity IgE receptor, but release IL-10 upon receptor activation. J Immunol 167:995–1003
Oliver JM, Kepley CL, Ortega E, Wilson BS (2000) Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcepsilonR1 signalling pathway. Immunopharmacology 48:269–281
Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet JP, Capron M (1994) High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 367:183–186
Cormier SA, Taranova AG, Bedient C, Nguyen T, Protheroe C, Pero R, Dimina D, Ochkur SI, O’Neill K, Colbert D, Lombari TR, Constant S, McGarry MP, Lee JJ, Lee NA (2006) Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol 79:1131–1139
Munitz A, Levi-Schaffer F (2004) Eosinophils: ‘new’ roles for ‘old’ cells. Allergy 59:268–275
MacGlashan DW Jr (1993) Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. J Allergy Clin Immunol 91:605–615
Coney LR, Mezzanzanica D, Sanborn D, Casalini P, Colnaghi MI, Zurawski VR Jr (1994) Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing. Cancer Res 54:2448–2455
Molthoff CF, Prinssen HM, Kenemans P, van Hof AC, den Hollander W, Verheijen RH (1997) Escalating protein doses of chimeric monoclonal antibody MOv18 immunoglobulin G in ovarian carcinoma patients: a phase I study. Cancer 80:2712–2720
Buijs WC, Tibben JG, Boerman OC, Molthoff CF, Massuger LF, Koenders EB, Schijf CP, Siegel JA, Corstens FH (1998) Dosimetric analysis of chimeric monoclonal antibody cMOv18 IgG in ovarian carcinoma patients after intraperitoneal and intravenous administration. Eur J Nucl Med 25:1552–1561
Acknowledgments
We are grateful to Dr. David Fear and Dr. Philippe Gevaert for providing generous technical expertise and advice and to Dr. Pooja Takhar for her helpful critical comments. We thank Ms. Kate Kirwan for expert assistance with the figures. We are grateful to Dr. Marie-Hélène Jouvin, Dr. Jean-Pierre Kinet, Dr. Silvana Canevari, Prof. Fu-Tong Liu, Dr. J. Hopp, and Prof. R. Korngold, for the generous provision of advice and materials. This study was supported by the Association for International Cancer Research, United Kingdom.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Karagiannis, S.N., Bracher, M.G., Beavil, R.L. et al. Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells. Cancer Immunol Immunother 57, 247–263 (2008). https://doi.org/10.1007/s00262-007-0371-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-007-0371-7